Cleerly ISCHEMIA vs DeepTek CXR Analyzer
AI Verdict
Choose Cleerly ISCHEMIA if…
Choose Cleerly ISCHEMIA if your primary goal is a detailed, non-invasive assessment of coronary artery disease and the likelihood of ischemia using CCTA scans. This tool is ideal for physicians needing to understand vessel-level plaque characteristics, stenosis severity, and functional impact to guide personalized treatment plans for heart disease.
View Cleerly ISCHEMIA →Choose DeepTek CXR Analyzer if…
Choose DeepTek CXR Analyzer if you aim to enhance the efficiency and accuracy of high-volume chest X-ray interpretations across a broad spectrum of pathologies. This AI-powered CADe solution is best suited for radiologists seeking to quickly identify and prioritize suspicious regions in lung, pleural, and cardiac areas, significantly reducing workload and improving diagnostic throughput.
View DeepTek CXR Analyzer →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly ISCHEMIA | DeepTek CXR Analyzer |
|---|---|---|
| Pricing | Unknown | Global access pricing available for eligible public sector and not-for-profit healthcare providers in 138 low- and middle-income countries, offering unlimited ai analyses per connected x-ray unit, installation, user training, product updates, maintenance, and technical support via an annual subscription. |
| Deployment | Web-based solution | On-premise and Cloud offerings. The solution supports online, offline, and hybrid deployment. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
DeepTek CXR AnalyzerDeepTek CXR Analyzer emphasizes seamless, backend PACS integration and a 'just a click' user experience, aiming to minimize workflow disruption. Its approach of sending secondary capture DICOMs with highlighted findings directly back to PACS, coupled with intelligent segregation, is designed for maximum efficiency within existing radiology workflows. Cleerly offers interactive web reports and PowerScribe integration, but DeepTek's integration appears more deeply embedded and less disruptive.
Clinical Value
Cleerly ISCHEMIACleerly ISCHEMIA provides a more profound and specific clinical value by offering non-invasive fractional flow reserve (FFR) estimation and detailed coronary plaque characterization from CCTA. This directly impacts personalized diagnosis and treatment planning for heart disease. Its robust clinical validation against invasive FFR and demonstrated prognostic utility for major adverse cardiovascular events (MACE) highlight its deep diagnostic and predictive capabilities.
Pricing & Value
DeepTek CXR AnalyzerDeepTek CXR Analyzer has a slight advantage due to its explicit 'pay-per-use' model, which offers more predictable and scalable cost management for healthcare providers, especially for high-volume imaging. While Cleerly ISCHEMIA has a Category I CPT code for reimbursement, its pricing structure is less transparent and 'varies by provider,' making it harder to assess upfront value compared to a clear usage-based model.
Enterprise Readiness
DeepTek CXR AnalyzerBoth tools are FDA-cleared, HIPAA compliant, and have BAAs, indicating strong readiness. However, DeepTek CXR Analyzer offers greater deployment flexibility with both cloud and on-premise options, which is crucial for diverse enterprise IT infrastructures. Its seamless DICOM-based PACS integration and broader global regulatory clearances further enhance its readiness for large-scale enterprise adoption.
Innovation
Cleerly ISCHEMIACleerly ISCHEMIA demonstrates higher innovation by non-invasively estimating fractional flow reserve (FFR) and providing detailed coronary plaque characterization from CCTA. This goes beyond traditional anatomical assessment, offering functional and prognostic insights for personalized treatment planning. It provides a '3-in-1 approach' for atherosclerosis, stenosis, and ischemia from a single CCTA test.
Support & Docs
DeepTek CXR AnalyzerDeepTek CXR Analyzer appears to offer more transparent and accessible support and documentation. Its explicit mention of a user manual linked in the DICOM output, along with a 'Resources Hub' that includes white papers, publications, and a 'Gateway Mobile App AI Bot,' suggests a more comprehensive and readily available support ecosystem for users.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly ISCHEMIA | DeepTek CXR Analyzer |
|---|---|---|
| Name | Cleerly ISCHEMIA | DeepTek CXR Analyzer |
| Company | Cleerly | DeepTek Medical Imaging Pvt |
| Description | Cleerly ISCHEMIA is an FDA-cleared AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease. | DeepTek CXR Analyzer is an FDA-cleared AI-powered CADe solution for chest X-ray analysis, designed to assist radiologists by automatically detecting and highlighting suspicious regions across lung, pleural, and cardiac pathologies, significantly improving workflow efficiency and diagnostic accuracy. |
| Key Features | AI-enabled CCTA analysis; Non-invasive fractional flow reserve (FFR) estimation; Vessel-level ischemia likelihood determination; Coronary plaque characterization (volume, type, location); Stenosis severity assessment; 3D digital models of coronary arteries; Comprehensive interactive web-based reports; Integration with PowerScribe via API | AI-Powered Computer-Assisted Detection (CADe) for Chest X-rays; Detection of 28 findings covering lung, pleural, cardiac pathologies, and hardware; Automatic identification, categorization, and highlighting of suspicious regions of interest (ROIs); Seamless DICOM-based PACS integration (on-premise or cloud); Intelligent segregation of scans into 'AI Finding-Negative' and 'AI Finding-Positive'; Reduces radiologist workload by 30-50% and boosts productivity by 2x-3x; Generates secondary capture DICOM with AI output for easy interpretation; Compatible with various X-ray modalities (hospital, mobile, portable, handheld) |
| Specialties | Cardiology, Radiology | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and DeepTek CXR Analyzer.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly ISCHEMIA or DeepTek CXR Analyzer
Backers
Who funded each tool's parent company.